3 Direct oral anticoagulants—with more predictable pharmacokinetics, greater ease of use, and equally good or better clinical outcomes than vitamin K antagonists—are the preferred anticoagulants for patients with atrial fibrillation.3 Of the 4 drugs in this class licensed in the US for use in ...
There are no adequate and well-controlled studies of Eliquis in pregnant women. Treatment is likely to increase the risk ofhemorrhageduring pregnancy and delivery. Eliquis should be used during pregnancy only if the potential benefit outweighs the potential risk to the mother and fetus. Women shoul...
There are no adequate and well-controlled studies of Eliquis in pregnant women. Treatment is likely to increase the risk ofhemorrhageduring pregnancy and delivery. Eliquis should be used during pregnancy only if the potential benefit outweighs the potential risk to the mother and fetus. Women shoul...